The expression of CD56 on malignant plasmocytes and bone disease in patients with multiple myeloma

被引：0
|
作者：
Buchler, Tomas [1 ]
Dolezelova, Eva [1 ]
Fabian, Pavel [2 ]
Pour, Ludek [1 ]
Moulis, Mojmir [3 ]
Kren, Leos [3 ]
Adam, Zdenek [1 ]
Krejci, Marta [1 ]
机构：
[1] Masaryk Univ Hosp, Dept Internal Med, Brno, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Pathol, Brno, Czech Republic
[3] Masaryk Univ Hosp, Inst Pathol Anat, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [21] Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma
    Cottini, Francesca
    Rodriguez, Jose
    Hughes, Tiffany
    Sharma, Nidhi
    Guo, Ling
    Lozanski, Gerard
    Liu, Bei
    Cocucci, Emanuele
    Yang, Yiping
    Benson, Don
    MOLECULAR CANCER RESEARCH, 2022, 20 (07) : 1083 - 1095
  • [22] INCREASED EXPRESSION OF CD56 AND HLA/DR ANTIGENS IN CD2+ CELLS FROM MULTIPLE-MYELOMA PATIENTS
    LAPENA, P
    PRIETO, A
    GARCIASUAREZ, J
    REYES, E
    SANMIGUEL, J
    JORDA, J
    ALVAREZMON, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (02) : 158 - 159
  • [23] Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients
    ElMenshawy, Nadia
    Farag, Nora A.
    Atia, Doaa M.
    Abousamra, Nashwa
    Shahin, Doaa
    Fawzi, Eman
    Ghazi, Hayam
    El-Kott, Attalla F.
    Eissa, Mohamed
    CANCER INVESTIGATION, 2021, 39 (09) : 777 - 782
  • [24] Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression
    Rawstron, A
    Barrans, S
    Blythe, D
    Davies, F
    English, A
    Pratt, G
    Child, A
    Morgan, G
    Jack, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) : 138 - 143
  • [25] Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma
    Dahl, IMS
    Rasmussen, T
    Kauric, G
    Husebekk, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) : 273 - 277
  • [26] LACK OF CD56 EXPRESSION IN MULTIPLE MYELOMA PATIENTS WITH RISS 2 DISEASE IS ASSOCIATED WITH WORSE PROGNOSIS AND ABOLISHED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
    Skerget, M.
    Skopec, B.
    Podgornik, H.
    Zontar, D.
    Rebersek, K.
    Furlan, T.
    Cernelc, P.
    HAEMATOLOGICA, 2017, 102 : 782 - 783
  • [27] CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma
    Benjamin, Reuben
    Condomines, Maud
    Gunset, Gertrude
    Sadelain, Michel
    CANCER RESEARCH, 2012, 72
  • [28] CD56 and EMA immunoexpressions in multiple myeloma: Any prognostic relevance?
    Dirilenoglu, F.
    Aydin, F.
    Kaya, E.
    Kalender, M. E.
    Ozdemirkiran, F.
    Kucukzeybek, B.
    Calli, A. O.
    VIRCHOWS ARCHIV, 2015, 467 : S201 - S201
  • [29] Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
    Geng, Chuanying
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Yang, Guangzhong
    Chen, Wenming
    BMC CANCER, 2022, 22 (01)
  • [30] Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
    Chuanying Geng
    Huixing Zhou
    Huijuan Wang
    Yanchen Li
    Yun Leng
    Zhiyao Zhang
    Yuan Jian
    Guangzhong Yang
    Wenming Chen
    BMC Cancer, 22
12345